1. Valsartan recall: global regulatory overview and future challenges;Farrukh;Ther Adv Drug Saf,2019
2. US Food and Drug Administration. FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan). Available at: https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-angiotensin-ii-receptor-blocker-arb-recalls-valsartan-losartan; Accessed 9 January 2023.
3. Recall of N-nitrosodimethylamine–contaminated pseudogeneric valsartan: best generics finally no better than others?;Leclerc;Canad J Cardiol,2018
4. Understanding the molecular-pharmaceutical basis of sartan recalls focusing on valsartan;Ray;Glob Cardiol Sci Pract,2020
5. US Food and Drug Administration. UPDATED: Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium and Hydrochlorothiazide Tablets, USP. Available at: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/updated-torrent-pharmaceuticals-limited-issues-voluntary-nationwide-recall-losartan-potassium; Accessed 9 January 2023.